Tisselli; Patrizia

Patent Applications and Registrations

Patent applications and USPTO patent grants for Tisselli; Patrizia.The latest application filed is for "tyrosine amide derivatives as rho- kinase inhibitors".

Company Profile

10.12.14

Tisselli; Patrizia - Parma IT
Tisselli; Patrizia - Saffron Walden GB
Tisselli; Patrizia - Essex GB
Tisselli; Patrizia - Harlow GB

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Tyrosine analogues derivatives as Rho-kinase inhibitors Grant 11,147,812 - Accetta , et al. October 19, 2	2021-10-19
Tyrosine Amide Derivatives As Rho- Kinase Inhibitors App 20210284639 - ACCETTA; Alessandro ; et al.	2021-09-16
Tyrosine amide derivatives as Rho-Kinase inhibitors Grant 10,954,236 - Accetta , et al. March 23, 2	2021-03-23
Tyrosine Analogues Derivatives As Rho-kinase Inhibitors App 20210023080 - ACCETTA; Alessandro ; et al.	2021-01-28
Meta Tyrosine Derivatives As Rho-kinase Inhibitors App 20200377500 - ACCETTA; Alessandro ; et al.	2020-12-03
Pyrazolopyrimidine derivatives as NIK inhibitors Grant 10,822,342 - Hynd , et al. November 3, 2	2020-11-03
Tyrosine Amide Derivatives As Rho- Kinase Inhibitors App 20200079774 - ACCETTA; Alessandro ; et al.	2020-03-12
Bicyclic dihydropyrimidine-carboxamide derivatives as Rho-Kinase inhibitors Grant 10,584,128 - Accetta , et al.	2020-03-10
Tyrosine amide derivatives as Rho-kinase inhibitors Grant 10,501,461 - Accetta , et al. Dec	2019-12-10
Thienopyrimidine derivatives as NIK inhibitors Grant 10,323,045 - Hynd , et al.	2019-06-18
New Pyrazolopyrimidine Derivatives As Nik Inhibitors App 20190169198 - HYND; George ; et al.	2019-06-06
Pyrazolopyrimidine derivatives as NIK inhibitors Grant 10,221,180 - Hynd , et al.	2019-03-05
New Thienopyrimidine Derivatives As Nik Inhibitors App 20180298032 - HYND; George ; et al.	2018-10-18
Tyrosine Amide Derivatives As Rho- Kinase Inhibitors App 20180215758 - Accetta; Alessandro ; et al.	2018-08-02
1-(4-pyrimidinyl)-1H-pyrrolo[3,2-c]pyridine derivatives as NIK inhibitors Grant 10,005,773 - Hynd , et al. June 26, 2	2018-06-26
Compounds as NIK inhibitors Grant 10,005,776 - Hynd , et al. June 26, 2	2018-06-26
Bicyclic Dihydropyrimidine-carboxamide Derivatives As Rho- Kinase Inhibitors App 20180170939 - Accetta; Alessandro ; et al.	2018-06-21
3-(1H-pyrazol-4-yl)-1H-pyrrolo[2,3-c]pyridine derivatives as NIK inhibitors Grant 9,981,963 - Hynd , et al. May 29, 2	2018-05-29
Pyrazole derivatives as NIK inhibitors Grant 9,981,962 - Hynd , et al. May 29, 2	2018-05-29
New Pyrazolopyrimidine Derivatives As Nik Inhibitors App 20170334915 - HYND; George ; et al.	2017-11-23
New Pyrazole Derivatives As Nik Inhibitors App 20170334900 - HYND; George ; et al.	2017-11-23
New Compounds As Nik Inhibitors App 20170334906 - HYND; George ; et al.	2017-11-23
3-(2-aminopyrimidin-4-yl)-5-(3-hydroxypropynyl)-1H-pyrrolo[2,3-C]pyridine derivatives as NIK inhibitors for the treatment of cancer Grant 9,643,964 - Hynd , et al. May 9, 2	2017-05-09
NEW 1-(4-PYRIMIDINYL)-1H-PYRROLO[3,2-c]PYRIDINE DERIVATIVES AS NIK INHIBITORS App 20160257679 - HYND; George ; et al.	2016-09-08
NEW 3-(1H-PYRAZOL-4-YL)-1H-PYRROLO[2,3-c]PYRIDINE DERIVATIVES AS NIK INHIBITORS App 20160229851 - HYND; George ; et al.	2016-08-11
3-(2-aminopyrimidin-4-yl)-5-(3-hydroxypropynyl)-1h-pyrrolo[2,3-c]pyridine Derivatives As Nik Inhibitors For The Treatment Of Cancer App 20160075699 - HYND; George ; et al.	2016-03-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.